0001744333-19-000001.txt : 20191202 0001744333-19-000001.hdr.sgml : 20191202 20191202152456 ACCESSION NUMBER: 0001744333-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191202 DATE AS OF CHANGE: 20191202 EFFECTIVENESS DATE: 20191202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELIXIRGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001744333 IRS NUMBER: 830534578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-354561 FILM NUMBER: 191263151 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 443-869-5420 MAIL ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 619 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001744333 ELIXIRGEN THERAPEUTICS, INC. 855 N. WOLFE ST. SUITE 619 BALTIMORE MD MARYLAND 21205 443-869-5420 DELAWARE Elixirgen Therapeutics, LLC None Corporation true 2017 Akihiro Ko 855 N. Wolfe Street Suite 619 Baltimore MD MARYLAND 21205 Executive Officer Director Minoru Ko 855 N. Wolfe Street Suite 619 Baltimore MD MARYLAND 21205 Director Naonori Kurokawa 855 N. Wolfe Street Suite 619 Baltimore MD MARYLAND 21205 Director Maiko Katadae 855 N. Wolfe Street Suite 619 Baltimore MD MARYLAND 21205 Director Biotechnology Decline to Disclose 06b false 2019-11-19 false true false 0 5006900 5006900 0 false 3 0 0 0 false ELIXIRGEN THERAPEUTICS, INC. Akihiro Ko Akihiro Ko CEO 2019-12-02